HPE
68
-5
NVDA
57
-2
EQR
47
2
NWL
57
3
ZTS
25
2
MTB
75
2
AEE
58
3
DTE
42
4
MAS
63
3
TROW
61
2
DVN
40
-2
F
58
2
PX
55
2
HSIC
62
-3
FTI
61
-2
AAPL
55
2
LNC
70
-2
TRIP
52
2
MO
57
4
PG
43
2
HPE
68
-5
NVDA
57
-2
EQR
47
2
NWL
57
3
ZTS
25
2
MTB
75
2
AEE
58
3
DTE
42
4
MAS
63
3
TROW
61
2
DVN
40
-2
F
58
2
PX
55
2
HSIC
62
-3
FTI
61
-2
AAPL
55
2
LNC
70
-2
TRIP
52
2
MO
57
4
PG
43
2
Financhill
Back

NYLI Candriam US Mid Cap Equity ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
53

IQSM
NYLI Candriam US Mid Cap Equity ETF

Last Price:
$35.34
Seasonality Move:
1.31%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
53
NYLI Candriam US Mid Cap Equity ETF (IQSM) is a Buy

Is NYLI Candriam US Mid Cap Equity ETF a Buy, Sell or Hold?

  • The current NYLI Candriam US Mid Cap Equity ETF [IQSM] share price is $35.31. The Score for IQSM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • IQSM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IQSM Stock Price Chart

What is NYLI Candriam US Mid Cap Equity ETF's stock price today?

  • The NYLI Candriam US Mid Cap Equity ETF share price today is $35.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IQSM is experiencing selling pressure, which indicates risk of future bearish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

IQSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.3 Buy
Relative Strength Index (14 RSI): 61.48 Buy
Chaikin Money Flow: -1236 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.82 - 35.18) Buy
Bollinger Bands (100): (33.35 - 34.63) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

IQSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.02 Buy
20-day SMA: 34.8 Buy
50-day SMA: 34.22 Buy
200-day SMA: 32.61 Buy
8-day EMA: 35.05 Buy
20-day EMA: 34.76 Buy
50-day EMA: 34.35 Buy
200-day EMA: 33.27 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

NYLI Candriam US Mid Cap Equity ETF Earnings Growth & IQSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

NYLI Candriam US Mid Cap Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):